Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Retro Therapy

Retro Therapy
2004 FOUNDED
PRIVATE STATUS
Grant LATEST DEAL TYPE
$227K LATEST DEAL AMOUNT
3 INVESTORS
Description

Developer of RNA (Ribonucleic acid) based therapuetics intended to be used for the treatment of human genetic diseases. The company's RNA (Ribonucleic acid) based therapuetics a new class of therapeutics that delivers therapeutic genes that can only be expressed in cells that contain viral RT, enabling healthcare practitioners to avail therapeutic drugs to selectively kill cells infected with retroviruses and preventing their spread.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Primary Office
  • 4519 Gretna Street
  • Bethesda, MD 20814
  • United States

+1 (301) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Retro Therapy’s full profile, request a free trial.

Retro Therapy Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Grant 01-Jan-2015 $227K 0000 Completed Startup
6. Grant 01-Jan-2014 00000 0000 Completed Startup
5. Grant 01-Jan-2011 00000 0000 Completed Startup
4. Grant 01-Jan-2010 00000 0000 Completed Startup
3. Grant 01-Jan-2007 0000 Completed Startup
2. Early Stage VC 04-Jan-2005 $50K $50K Completed Startup
1. Grant Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Retro Therapy Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
National Science Foundation Government 000 0000 000000 0
Maryland Stem Cell Research Fund Government 000 0000 000000 0
TEDCO Venture Capital Minority 000 0000 000000 0

Retro Therapy Executive Team (1)

Name Title Board
Seat
Contact
Info
Lloyd Mitchell MD Founder, Chief Executive Officer & Chief Scientific Officer